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Abstract
Background: In this study, we report a rare case of an adult patient with essential palatal tremors (EPT) presenting
as nasal clicks, instead of otic clicks or objective pulsatile tinnitus in common EPT.
Case presentation: Nasal endoscopic examination and EMG recordings of the soft palate muscles were performed
to confirm the source of the clicks. Initial treatment with lidocaine provided symptomatic relief for four hours. The
patient was then treated with four simultaneous injections of 12.5 U of botulinum toxin in four different sites of the
soft palate. Palatal tremors and clicks completely disappeared within three months of treatment.
Conclusions: To our knowledge, this is the first case of EPT that presented with nasal clicks. We recommend that
otolaryngologists should expect this rare occurrence in the clinical setting, and handle patients presenting with
such symptoms with care and compassion in order not to worsen their psychological status.
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Background
Palatal tremor i.s a rare movement disorder character-
ized by continuous rhythmic jerks of the soft palate that
are often perceived as tinnitus [1]. Palatal tremors are
classified as symptomatic palatal tremors (SPTs) and es-
sential palatal tremors (EPTs). SPTs mainly present with
neurological deficits such as dysarthria, nystagmus and
ataxia. Abnormalities in the function of the nucleus den-
tatus, nucleus ruber and/or inferior olivary complex are
known to contribute to the pathophysiology of SPT [2,
3]. SPTs rarely present with ear clicks and palatal move-
ments, while EPTs almost exclusively present with ear
clicks and palatal movements. Excessive contraction of the
tensor veli palatini (TVP) muscle, which is innervated
by the trigeminal nerve, is thought to be the cause of
EPTs. According to the diagnostic criteria proposed
by Deuschl et a1. [3, 4], no intracranial pathology is
associated with EPTs. Patients have normal cerebellar
function and pendular nystagmus. Furthermore, throat
muscle involvement is not expected. In the literature,
several cases of EPT associated with psychogenic
factors, as well as those of unknown etiology, have
been reported [5, 6].
Regardless of etiology, EPTs usually present with ob-
jective tinnitus of otic origin or ear clicks. However,
EPTs with nasal clicks have hitherto not been reported.
Here, we report the case of an adult patient with EPT
presenting as nasal clicks who was effectively treated
with botulinum toxin injection.
Case presentation
Patient history
A previously healthy 51-year-old man presented at our
hospital with a chief complaint of clicking sounds heard in
the nose. He mentioned that the noise was audible to
others and disappeared during sleep. He had excessive
phlegm for two years and pharyngalgia for one week. His
birth, growth and developmental history were all normal.
He had no history of head trauma, chronic ear disease, or
neurological disorder. None of his family members had a
history of nasal clicks or tinnitus. The patient had been
very uncomfortable due to the persistent sound.
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Physical examination and preliminary diagnosis
An otolaryngologist performed physical examination of
the nose, mouth and pharynx; and found that the aud-
ible “clicking” noise originated from the nose (Additional
file 1: Video S1). No anomaly other than a fast rhythmic
tremor of the soft palate was observed upon physical
examination. Other muscles in the pharynx, mouth and
eyes did not seem to be involved based on these exami-
nations. Results of audiometry, tympanometry and
neurologic examinations including cranial magnetic res-
onance imaging (MRI) and neurological physical exami-
nations were all normal. Rhythmic palatal movements
produced a high-pitched “clicking” sound with a frequency
of approximately 100 clicks per minute (Additional file 1:
Video S1, Additional file 2: Video S2 and Additional file 3:
Video S3). The examiner could clearly hear the sound at a
distance of 10 cm from the nasal tip. When the patient
was asked to tilt his neck slightly backward, the noise was
reduced (Additional file 4: Video S4).
Laboratory results including routine blood work, anti-
nuclear antibody analysis, thyroid tests, and hepatic and
renal functions tests were all normal (Table 1). Com-
puted tomography (CT) scans of the brain and cervical
region did not show any abnormalities. A nasal sinus CT
scan revealed fungal maxillary sinusitis on the left side
(Fig. 1), which was treated by functional endoscopic
sinus surgery. No signs of olivary nucleus hypertrophy
or occupying lesions of the skull base were visible on
MRI scans (Fig. 2).
Nasal endoscopic examination and sinus surgery
We then performed a nasal endoscopic examination. In-
voluntary rhythmic movements of the nasopharyngeal
lateral wall or muscles surrounding the eustachian tube
were not observed (Additional file 2: Video S2 and
Additional file 3: Video S3). However, the torus tubarius
was found to be involved. We identified the source of
the clicks on the basis of the adjacency of the sound to
the nose and throat. Thus, the nasal cavity was con-
firmed as the source of the sound.
Endoscopic sinus surgery was performed to open the
left maxillary sinus. The patient was placed in the supine
position. After endotracheal intubation and routine dis-
infection, sterile drapes were placed and the operation
commenced. An adrenaline cotton sheet was placed in
the left nasal mucosa to absorb nasal secretions. The
middle turbinate root, agger and uncinate process of the
left side were locally anesthetized by injecting lidocaine-
containing adrenaline. Under 0° endoscopy, the left un-
cinate process was lifted by a nasal probe, and the tail
section of the uncinate process was separated. The
upper and lower ends of the uncinate process adjacent
to the lateral nasal wall were excised with a curved scis-
sor. The separated uncinate process was removed with
an ethmoidal sinus forcep. Thereafter, the bone at the
tail end of the uncinate process was removed with a
detacher and the anterior fontanelle was removed with a
back biting rongeur. Thus, the natural orifice of the
maxillary sinus was expanded. The maxillary sinus
observed with 70° endoscopy revealed several brown
bean-curd-residue-like lesions. A subsequent patho-
logical examination confirmed that they were mould
clumps. We cleaned the lesions, flushed the maxillary
sinus cavity with saline via a curved suction tube, and
ensured that the sinus mucosa was smooth and with-
out any residual lesions. The left nasal cavity was
filled with one expansion sponge, and the operation
was completed.
However, the “clicking” noise did not stop. In a follow-
up exam three months after surgery, we confirmed that
the ostium of the left maxillary sinus had significantly
opened up, and the sinus was clean.
Electromyography
To determine the etiology of the nasal click, we recorded
the activities of the soft palatal muscles including the TVP,
palatopharyngeus, palatoglossus, levator veli palatini (LVP),
and uvularis muscles by direct electromyography (EMG,
Fig. 3). All the above-mentioned muscles except the TVP
revealed abnormal waveforms. This was a highly unusual
finding. The TPV is usually the main muscle associated
with EPT. However, our EMG results revealed that all other
muscles except the TVP were causing these contractions.
Treatment
The nasal clicks significantly affected the patient’s social
life. The patient did not receive any other treatment
from other hospitals before he arrived at our hospital.
To explore whether blocking nerve impulse conduction
can weaken or eliminate the tremors, we first injected
0.5 mL of 2% lidocaine into the palatal muscles includ-
ing the palatopharyngeus, palatoglossus, LVP and uvu-
laris muscles. Palatal tremors disappeared, but returned
within four hours given that the effective time of lidocaine
anesthesia is approximately 1.5 h. When the patient visited
our hospital a week later, we modified the treatment
strategy. Botulinum toxin was injected into four different
regions (dose, 12.5 U/site) of the soft palatine (Fig. 4). The
patient tolerated the injections well on the first day. On
the second day, the patient experienced dragging pain,
and his tongue twisted involuntarily when he had to
open his mouth wide. Two weeks later, the pain sub-
sided, and his lisp disappeared. The patient did not
complain of excessive phlegm thereafter. No other
side effects such as choking after drinking or diffi-
culty in swallowing were reported. Three months after
receiving botulinum toxin injections, the palatal tremors
disappeared; and the patient felt well. However, eight
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Table 1 Laboratory results including routine blood work, antinuclear antibody analysis, thyroid tests, and hepatic and renal functions
Test name Abbreviations Item name Results Ref Unit OD value
Hepatitis B virus HBSAG HbsAg 0.688 (Negative) <1.000 COI 0.688
AHBS Anti-HBs 2.00 (Negative) IU/L 2.000
HBEAG HbeAg 0.101 (Negative) <1.000 COI 0.101
AHBE Anti-Hbe 1.56 (Negative) >1.000 COI 1.560
AHBC Anti-HBc 1.89 (Negative) >1.000 COI 1.890
HIV,HCV,TPHA HIV HIV antibodies (screen) Negative Negative 0
HCV Anti-HCV Negative Negative 0





ALT Glutamic-pyruvic transaminase 19 0 ~ 50 U/L 19.000
AST Glutamic oxalacetic
transaminase
18 15 ~ 45 U/L 18.000
AS/AL AST/ALT 0.95 0.947
ALP Alkaline phosphatase 95 45 ~ 125 U/L 95.000
GGT Glutamyl transpeptidase 35 10 ~ 60 U/L 35.000
TP Total protein 78.9 61.0 ~ 79.0 g/L 78.900
ALB Albumin 44.9 34.0 ~ 48.0 g/L 44.900
GLO Globulin 34.0 24.8 ~ 38.8 g/L 34.000
A/G ALB/GLB 1.3 1.2 ~ 2.0 1.321
TBIL Total bilirubin 10.4 6.8 ~ 34.2 μmol/L 10.400
DBIL Direct bilirubin 1.5 1.7 ~ 8.6 μmol/L 1.500
IBIL Indirect bilirubin 8.9 4.8 ~ 25.0 μmol/L 8.900
GLU-S Fasting blood-glucose 5.53 3.90 ~ 6.10 mmol/L 5.530
BUN Serum urea 3.82 2.90 ~ 8.20 mmol/L 3.820
CREA Creatinine 91.2 50.0 ~ 133.0 μmol/L 91.200
BU/CR Serum urea/Creatinine 0.042 0.03 ~ 0.15 0.042
UA Uric acid 260 149 ~ 416 μmol/L 260.000
NA Sodium 137.5 137.0 ~ 147.0 mmol/L 137.500
K Kalium 4.33 3.50 ~ 5.30 mmol/L 4.330
CL Chlorine 105.3 99.0 ~ 110.0 mmol/L 105.300
Routine stool test YS Color Yellow 0
JD Toughness Soft 0
NY Mucus Negative 0
BXQ White blood cells (stool) Negative /High power field 0
HXB Red blood cells (stool) Negative /High power field 0
NC Pyocyte Not found /Low power field 0
AMB Amebic protozoa Not found Not found 0
JMJ Saccharomycopsis Not found Not found 0
HCL Ova of roundworm Not found Not found 0
NX Purulent blood Negative Negative 0
CL Ovum Not found Not found 0
JSC Parasite Not found 0
Urine routines COLOR Color Faint yellow 2.000
TURB Turbidity Clear 0
WBC Leukocyte count 0.54 /High power field 0.540
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Table 1 Laboratory results including routine blood work, antinuclear antibody analysis, thyroid tests, and hepatic and renal functions
(Continued)
WBC1 Leukocyte count 3.00 /μl 3.002
RBC Erythrocyte count 1.80 /High power field 1.800
RBC1 Erythrocyte count 10.01 /μl 10.008
TMGX Hyaline cast 2.90 /Low power field 2.900
WFLGX Granular casts Negative Negative /Low power field −2.900
CG Cellular cast Negative Negative /Low power field −2.900
LZSP Squamous epithelial cell 5.80 /Low power field 2.000
BLD Urine occult blood Weakly positive (±) Negative 0
BIL Urine bilirubin Negative Negative 0
URO Urobilinogen Negative Negative 0
KET Urine acetone bodies Negative Negative 0
PRO Qualitative test of urinary
protein
Weakly positive (±) Negative 0
SG Urine specific gravity 1.019 1.003 ~ 1.03 1.019
NIT Nitrite Negative Negative 0
GLU Urine sugar Negative Negative 0
PH pH 7.0 4.6 ~ 8 7.000
LEU Neutrophil esterase Negative Negative 0
Blood coagulation PT Prothrombin time 12.00 12.00 ~ 15.00 Second 12.000
PTS-CP Normal controls (PT) 12.50 Second 12.500
INR International normalized ratio 0.95 0.85 ~ 1.15 0.950
APTT Activated partial
thromboplastin time
32.10 30.00 ~ 45.00 Second 32.100
APTTS- Normal controls (APTT) 35.00 Second 35.000
TT Thrombin time 16.30 14.00 ~ 18.00 Second 16.300
FIB Fibrinogen 2.95 2.00 ~ 4.00 g/L 2.950
BBBC Sample preservation The sample retained
for three days
1.000
Blood routine WBC Leukocyte count 7.00 4 ~ 10 ×10^9/L 7.000
NEUT% Ratio of neutrophil 0.647 0.647
LYMPH% Ratio of lymphocyte 0.286 0.286
MONO% Ratio of monocytes 0.044 0.044
EO% Ratio of eosinophils 0.013 0.013
BASO% Ratio of basophils 0.006 0.006
IG% Ratio of immature
granulocytes
0.004 0.004
YC1 Annormal lymphocytes Not found 0
YZXB5 Juvenile cells Not found 0
NEUT# Neutrophil count 4.529 ×10^9/L 4.529
LYMPH# Lymphocyte count 2.002 ×10^9/L 2.002
MONO# monocyte count 0.308 ×10^9/L 0.308
EO# eosinophil count 0.091 ×10^9/L 0.091




HGB Hemoglobin 148 120 ~ 160 g/L 148.000
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months after the botulinum toxin injections, the palatal
tremors recurred; but the frequency of the tremors and
number of attacks were reduced. Rapid contractions of
the velar muscles sometimes occurred when he was ner-
vous or tired, or had consumed alcohol; but he could con-
trol them voluntarily (Additional file 5: Video S5). An
EMG test at this point showed complete relief of the LVP
and uvularis muscles besides palatoglossus and
palatopharyngeus.
Discussion
Auditory clicks arising from the rhythmic contraction of
any of the muscles in the ear and throat [1, 2] are regarded
as a primary symptom of EPT. The case of our patient
was unique, because the clicks were nasal in origin.
The tremors would stop when the patient was asleep.
The palatal tremor cycle could not be restored by inhib-
ition of the trigeminal nerve using lidocaine. Neuro-
logical examination results and brain MRI scans were
normal. MRI scans have shown increased signal intensity
on T2 weighted images in SPT patients with injury to
the dentate-olivary complex, indicating hypertrophy of
the olivary nucleus [7, 8]. MRI scans of our patient re-
vealed no evidence of structural abnormalities. Thus,
SPT was excluded as a cause. To our knowledge, this is
the first case of EPT associated with nasal clicks instead
of otic clicks.
Table 1 Laboratory results including routine blood work, antinuclear antibody analysis, thyroid tests, and hepatic and renal functions
(Continued)
RBC Erythrocyte count 4.88 4 ~ 5.5 ×10^12/L 4.880
HCT Hematokrit 0.429 0.4 ~ 0.54 0.429
MCV Mean corpuscular
volume
87.90 80 ~ 100 fl 87.900
MCH Mean corpuscular
hemoglobin
30.30 27 ~ 34 pg 30.300
MCHC Mean corpuscular-
hemoglobin concentration
345 320 ~ 360 g/L 345.000
RDW-CV Red cell distribution
width-CV
13.0 11.6 ~ 14.6 % 13.000
RDW-SD Red cell distribution
width-SD
41.5 fl 41.500
PLT platelets counts 334 100 ~ 300 ×10^9/L 334.000
PCT Thrombocytocrit 0.34 0.11 ~ 0.28 0.340
MPV Mean platelet volume 10.30 6.5 ~ 11 fl 10.300
P-LCR Platelet-large cell ratio 27.40 % 27.400
PDW Platelet distribution width 12.30 9 ~ 17 % 12.300
ZDKL Toxic granulation Negative 0
YHH Nucleated red blood cell
count
0.0 /100WBC 0
YCC Abnormal cell Not found 0
BBBC Sample preservation The sample retained
for three days
1.000
Blood type ABO ABO blood group system AB 0
RH RH(D) blood group Positive 0
Thyroid function tests TOTT3 Total T3 0.78 0.87 ~ 1.78 ng/ml 0.780
TOTT4 Total T4 7.01 6.10 - 12.20 μg/dl 7.010
FT3 Free T3 2.52 2.50 ~ 3.90 pg/ml 2.520
FRT4 Free T4 0.88 0.61 ~ 1.12 ng/dl 0.880
TSH Thyroid stimulating
hormone
1.06 0.34 ~ 5.60 μIU/ml 1.060
Bronchofiberscope Mould Not found 0
Smear results Found no acid fast
bacilli
0
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Otic clicks are caused by abnormal contractions of
both the TVP and LVP muscles. However, objective otic
clicks due to LVP contractions have not been reported
since 1996 [9]. In our patient, otic clicks were com-
pletely absent (Additional file 1: Video S1). Therefore,
we suspected that some muscles of the soft palate other
than the TVP such as the palatopharyngeus, palatoglos-
sus, uvularis, and/or LVP muscles contributed to the
nasal clicks. EMG results confirmed that all the above
muscles were involved, except the TVP.
EPT clicks are affected by mouth opening, speaking
[9], head position [10] and relaxation [11]. In our pa-
tient, tilting the head backwards and speaking could
completely suppress the tremors.
No specific treatment has been reported for EPT. In
1997, Cakmur et al. [12] reported that a 16-year old girl,
who had been diagnosed with EPT at the age of six, was
successfully treated with flunarizine, which is a selective
calcium entry blocker with antihistaminic, antiserotoni-
nergic and antidopaminergic activity [13]. However, the
Fig. 1 Coronal CT image of sinuses, indicating fungal rhinosinusitis of the left maxillary sinus
Fig. 2 Cranial MRI image of the horizontal position. No occupying lesions or abnormal signal of the inferior olive was observed
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tremor was found to recur after flunarizine was
discontinued.
Campistol-Plana et al. [14] suggested that TPV and
tubal pharynx muscles are controlled by the glossopha-
ryngeal nerve and pharyngeal plexus. Their treatment of
four pediatric patients with 2% lidocaine resulted in the
gradual disappearance of palatal tremors.
Nasr and Brown reported that a 37-year-old man with
a history of alcohol abuse, palatal tremors and ear clicks,
and who had been hospitalized for excessive alcohol in-
take, has shown gradual improvement of ear clicks and
frequency of tremors after being treated with lamotri-
gine, which is a sodium channel blocking antiepileptic
drug [15]. However, the long-term success of this drug
could not be determined, because the patient discontin-
ued its use after being discharged from the hospital.
Botulinum toxin is a neurotoxin that blocks neuro-
muscular transmission by inhibiting the acetylcholine re-
ceptor. Since the establishment of botulinum toxin as a
safe and tolerable treatment for various therapeutic indi-
cations [16] including migraine [17], cerebral palsy [18],
and cervical and maxillofacial conditions [19], it has
been sporadically tested for treating EPTs.
In some cases, botulinum toxin was directly injected into
the soft palate to ameliorate symptoms [20, 21]. Its efficacy
in EPT stems from the fact that it binds to cholinergic
nerve endings and causes muscular paralysis, thereby redu-
cing muscular contractions. Its long-term use has not been
found to cause permanent muscular degeneration [22, 23].
Recently, Tobias et al. [24] reported that long-term
botulinum toxin injections could relieve objective tin-
nitus in a 78-year-old woman with minimal side effects.
However, the toxin yielded temporary effects and had to
be administered every 5–6 months to prevent recurrence
of symptoms that could affect the daily activities of the
patient.
Fig. 3 EMG recordings of palatal tremor activities are shown
Fig. 4 Sites of botulinum toxin injections
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Anis and Pollak reported that a 36-year-old woman
with EPT, who had failed to respond to conservative
treatment with anxiolytics, was successfully treated with
2–3 injections of botulinum toxin [25]. Symptomatic re-
lief was obtained within two days of injection.
Even though the source of the clicks in our patient was
different from that reported in previous cases, we applied
symptom-guided injections of botulinum toxin in our
patient. Unlike the temporary relief provided by lidocaine
injections, four simultaneous injections of botulinum
toxin were found to diminish the tremors in our patient.
Although our patient tolerated the treatment well, allevi-
ation of symptoms required at least two weeks. Variability
in time and dosage required for symptomatic relief in our
patient and in patients reported in previous studies sug-
gests that individualized titration of dose and frequency by
close monitoring of symptoms may be critical in achieving
long-term benefits, as suggested by Anis and Pollak [25].
Although the etiology of EPT remains unclear, some
patients were found to have minor ailments [26] or
symptoms such as otitis media, fever, or tonsillitis before
the occurrence of EPTs. Our patient had excessive
phlegm for two years and pharyngalgia for one week.
We believe that these symptoms could be related to the
etiology of EPT, because they were spontaneously re-
lieved within 15 days after botulinum toxin treatment.
Additional studies will be required to determine the
pathogenesis of EPT with nasal clicks, as well as the oc-
currence of phlegm and pharyngalgia.
Conclusions
Tinnitus is the most common symptom of EPT. In this
study, we report the first case of a patient with EPT who
presented with nasal clicks, instead of objective pulsatile
tinnitus. Similar to previous reports, botulinum toxin in-
jections were found to alleviate symptoms and improve
the quality of life of the patient for up to three months.
Although the detailed pathophysiology and etiology of
EPT that presented with nasal clicks remains unclear, we
recommend that otolaryngologists should expect this
rare occurrence in the clinical setting. Patients with this
rare disorder usually have a poor social life. Therefore,
clinicians should exercise care, patience and attention
when handling such cases in order not to worsen the
psychological status of the patient.
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